IGI Reports Fourth Quarter and Full Year 2023 Condensed and Unaudited Financial Results
Highlights for the fourth quarter and full year of 2023 include:
|
(in millions of |
||||
|
|
Quarter Ended |
Year Ended |
||
|
|
2023 |
2022 |
2023 |
2022 |
|
Gross written premiums |
|
|
|
|
|
Net premiums earned |
|
|
|
|
|
Underwriting income (2) |
|
|
|
|
|
Net investment income (1) |
|
|
|
|
|
Net income for the period |
|
|
|
|
|
Combined ratio (2) |
81.8% |
92.1% |
76.7% |
78.5% |
|
Earnings per share (diluted) (3) |
|
|
|
|
|
Return on average equity (annualized) (4) |
26.1% |
22.7% |
24.8% |
22.5% |
|
Core operating income (4) |
|
|
|
|
|
Core operating earnings per share (diluted) (4) |
|
|
|
|
|
Core operating return on average equity (annualized) (4) |
23.7% |
13.7% |
28.1% |
23.7% |
|
(1) |
See Note (1) in the “Notes to the Consolidated Financial Statements (Unaudited)” below. |
|
|
(2) |
See “Supplementary Financial Information” below. |
|
|
(3) |
See Note (2) in the “Notes to the Consolidated Financial Statements (Unaudited)” below. |
|
|
(4) |
See the section titled “Non-GAAP Financial Measures” below. |
“Market conditions remained positive through the
“While the world around us has become increasingly polarized and our industry increasingly challenged,
Results for the Periods Ended
Net income for the quarter ended
Core operating income, a non-GAAP measure, was
Net income for the year ended
Core operating income was
Underwriting Results
Underwriting income increased 76.1% to
Gross written premiums were
The loss ratio was 47.6% for the quarter ended
The net policy acquisition expense ratio was 14.5% in the fourth quarter of 2023 compared to 18.8% in the same quarter of 2022.
The combined ratio for the quarter ended
Underwriting income increased 23.2% to
Gross written premiums were
The loss ratio was 42.3% for the year ended
The net policy acquisition expense ratio was 16.8% in the full year of 2023 compared to 18.7% for the same period of 2022.
The combined ratio for the year ended
Segment Results
The Long-tail Segment, which represented 33% of the Company’s gross written premiums for the full year 2023, recorded gross written premiums of
Gross written premiums for the full year of 2023 were
The Short-tail Segment, which represented 58% of the Company’s gross written premiums for the full year 2023, recorded gross written premiums of
Gross written premiums for the full year of 2023 were
The Reinsurance Segment, which represented 9% of the Company’s gross written premiums for the full year 2023, was impacted during the fourth quarter of 2023 by prior period premium adjustments, resulting in gross written premiums of negative
Gross written premiums for the full year of 2023 were
Net Foreign Exchange Gain (Loss)
The gain on foreign exchange in the fourth quarter of 2023 was
The gain on foreign exchange for the full year of 2023 was
Change in Fair Value of Derivative Financial Liabilities
The change in fair value of derivative financial liabilities consists of the following:
|
(in millions of |
Quarter Ended |
|
Year Ended |
|||||
|
|
2023 |
|
2022 |
|
2023 |
|
2022 |
|
|
|
|
|
|
|
||||
|
Change in fair value of warrants* |
|
( |
( |
|
||||
|
Change in fair value of earnout shares** |
( |
( |
( |
|
||||
|
|
( |
( |
( |
|
||||
* The negative movement in the year ended
** The negative movement in the fourth quarter and year ended
Investment Results
Net investment income was
Net investment income was
Total Shareholders’ Equity
Total shareholders’ equity at
|
(in millions of |
Quarter Ended |
Year Ended |
|
Total Shareholders’ equity at beginning of period |
|
|
|
Net income for the period |
|
|
|
Unrealized gains arising during the period for available-for-sale investments |
|
|
|
Purchase of treasury shares (a) |
( |
( |
|
Issuance of common shares under share-based compensation plan |
|
|
|
Vesting of earnout shares |
|
|
|
Cash dividends declared during the period |
( |
( |
|
Total shareholders’ equity at |
|
|
Book value per share was
|
(a) |
In the fourth quarter of 2023, the Company repurchased approximately 401,980 common shares at an average price per share of |
Consolidated Statements of Income (Unaudited)
|
|
Quarter Ended |
|
Year Ended |
|||||
|
|
|
|
|
|
|
|
||
|
(in millions of |
2023 |
|
2022 |
|
2023 |
|
2022 |
|
|
|
|
|
|
|
||||
|
Gross written premiums |
|
|
|
|
||||
|
Ceded written premiums |
( |
( |
( |
( |
||||
|
Net written premiums |
|
|
|
|
||||
|
Net change in unearned premiums |
( |
( |
( |
( |
||||
|
Net premiums earned |
|
|
|
|
||||
|
Investment Income(1) |
|
|
|
|
||||
|
Net realized gain (loss) on investments(1) |
|
( |
|
( |
||||
|
Net unrealized gain (loss) on investments(1) |
|
|
|
( |
||||
|
Change in allowance for expected credit losses on investments(1) |
|
( |
|
( |
||||
|
Change in fair value of derivative financial liabilities. |
( |
( |
( |
|
||||
|
Other revenues |
|
|
|
|
||||
|
Total revenues |
|
|
|
|
||||
|
Expenses |
|
|
|
|
||||
|
Net loss and loss adjustment expenses |
( |
( |
( |
( |
||||
|
Net policy acquisition expenses |
( |
( |
( |
( |
||||
|
General & administrative expenses |
( |
( |
( |
( |
||||
|
Change in allowance for expected credit losses on receivables |
( |
( |
( |
( |
||||
|
Other expenses |
( |
( |
( |
( |
||||
|
Net Foreign exchange gain (loss) |
|
|
|
( |
||||
|
Total expenses |
( |
( |
( |
( |
||||
|
Net income before tax |
|
|
|
|
||||
|
Income tax expense |
( |
( |
( |
( |
||||
|
Net income for the period |
|
|
|
|
||||
|
Diluted earnings per share attributable to equity holders (2) |
|
|
|
|
||||
See “Notes to the Consolidated Financial Statements (Unaudited)” below.
Consolidated Balance Sheets (Unaudited)
|
|
As at |
||
|
(in millions of |
2023 |
|
2022 |
|
ASSETS |
|
|
|
|
Investments |
|
|
|
|
Fixed maturity securities available-for-sale, at fair value |
|
|
|
|
Fixed maturity securities held to maturity |
|
|
|
|
Equity securities, at fair value |
|
|
|
|
Other investments |
|
|
|
|
Short-term investments |
|
|
|
|
Term deposits |
|
|
|
|
Equity-method investments measured at fair value |
|
|
|
|
Cash and cash equivalents |
|
|
|
|
Accrued investment income |
|
|
|
|
Premiums receivable |
|
|
|
|
Reinsurance recoverables |
|
|
|
|
Ceded unearned premiums |
|
|
|
|
Deferred policy acquisition costs, net of ceding commissions |
|
|
|
|
Deferred tax assets, net |
|
|
|
|
Other assets |
|
|
|
|
TOTAL ASSETS |
|
|
|
|
|
|
|
|
|
LIABILITIES |
|
|
|
|
Reserve for unpaid loss and loss adjustment expenses |
|
|
|
|
Unearned premiums |
|
|
|
|
Other liabilities |
|
|
|
|
Insurance and reinsurance payables |
|
|
|
|
Derivative financial liabilities |
|
|
|
|
TOTAL LIABILITIES |
|
|
|
|
|
|
|
|
|
SHAREHOLDERS’ EQUITY |
|
|
|
|
Common shares at par value |
|
|
|
|
Additional paid-in capital |
|
|
|
|
Accumulated other comprehensive income, net of taxes |
|
|
|
|
Foreign currency translation reserve |
( |
( |
|
|
Fair value reserve |
( |
( |
|
|
Retained earnings |
|
|
|
|
TOTAL SHAREHOLDERS’ EQUITY |
|
|
|
|
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY |
|
|
|
See “Notes to the Consolidated Financial Statements (Unaudited)” below.
Supplementary Financial Information – Combined Ratio (Unaudited)
|
|
Quarter Ended |
Year Ended December 31, |
|||||||||
|
|
2023 |
2022 |
2023 |
2022 |
|||||||
|
|
|
|
|
|
|||||||
|
Loss ratio (a) |
47.6 |
% |
55.6 |
% |
42.3 |
% |
41.9 |
% |
|||
|
Net policy acquisition expense ratio (b) |
14.5 |
% |
18.8 |
% |
16.8 |
% |
18.7 |
% |
|||
|
General and administrative expense ratio (c) |
19.7 |
% |
17.7 |
% |
17.6 |
% |
17.9 |
% |
|||
|
Expense ratio (d) |
34.2 |
% |
36.5 |
% |
34.4 |
% |
36.6 |
% |
|||
|
Combined ratio (e) |
81.8 |
% |
92.1 |
% |
76.7 |
% |
78.5 |
% |
|||
|
(a) |
Represents net loss and loss adjustment expenses as a percentage of net premiums earned. |
|
|
(b) |
Represents net policy acquisition expenses as a percentage of net premiums earned. |
|
|
(c) |
Represents general and administrative expenses as a percentage of net premiums earned. |
|
|
(d) |
Represents the sum of the net policy acquisition expenses ratio and the general and administrative expense ratio. |
|
|
(e) |
Represents the sum of the loss ratio and the expense ratio. |
Supplementary Financial Information – Book Value per Share (Unaudited)
|
|
As at |
|||
|
(in millions of |
2023 |
|
2022 |
|
|
Investments |
|
|
||
|
Cash and cash equivalents |
|
|
||
|
Total investments and cash and cash equivalents |
|
|
||
|
|
|
|
||
|
Common shares outstanding (in millions)* |
46.1 |
49.0 |
||
|
Minus: Unvested shares (in millions)** |
2.5 |
3.7 |
||
|
Number of vested common outstanding shares (in millions) (a) |
43.6 |
45.3 |
||
|
|
|
|
||
|
Total shareholders’ equity (b) |
|
|
||
|
Book value per share (b)/(a) |
|
|
||
|
* Common shares issued and outstanding as at |
|
|
No. of shares as at |
|
|
|
|
Vested common shares as of |
45,306,928 |
|
Vested restricted share awards |
298,859 |
|
|
1,668 |
|
Cancelled treasury shares |
(3,419,106) |
|
Vested earnout shares |
1,400,000 |
|
|
(3,800) |
|
Total vested common shares as of |
43,584,549 |
|
|
|
|
Unvested earnout shares as of |
1,612,500 |
|
Unvested restricted share awards as of |
877,130 |
|
Total unvested shares as of |
2,489,630 |
|
Total common shares outstanding |
46,074,179 |
|
|
No. of shares as at |
|
|
|
|
Vested common shares as of |
45,471,084 |
|
Vested restricted share awards |
146,386 |
|
Cancelled treasury shares |
(308,874) |
|
|
(1,668) |
|
Total vested common shares as of |
45,306,928 |
|
|
|
|
Unvested earnout shares as of |
3,012,500 |
|
Unvested restricted share awards as of |
667,181 |
|
Total unvested shares as of |
3,679,681 |
|
Total common shares outstanding |
48,986,609 |
|
** |
Earnout Shares are subject to vesting at stock prices ranging from |
Supplementary Financial Information - Segment Results (Unaudited)
|
Segment information for IGI’s consolidated operations is as follows: |
|
For the quarter ended |
|||||||
|
(in millions of |
Specialty |
|
Specialty |
|
Reinsurance |
|
Total |
|
Underwriting revenues |
|
|
|
|
|
|
|
|
Gross written premiums |
|
|
|
|
( |
|
|
|
Ceded written premiums |
( |
|
( |
|
- |
|
( |
|
Net written premiums |
|
|
|
|
( |
|
|
|
Net change in unearned premiums |
|
|
( |
|
|
|
( |
|
Net premiums earned |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss and loss adjustment expenses |
( |
|
( |
|
( |
|
( |
|
Net policy acquisition expenses |
( |
|
( |
|
( |
|
( |
|
Underwriting income |
|
|
|
|
|
|
|
|
For the quarter ended |
|||||||
|
(in millions of |
Specialty |
|
Specialty |
|
Reinsurance |
|
Total |
|
Underwriting revenues |
|
|
|
|
|
|
|
|
Gross written premiums |
|
|
|
|
|
|
|
|
Ceded written premiums |
( |
|
( |
|
- |
|
( |
|
Net written premiums |
|
|
|
|
|
|
|
|
Net change in unearned premiums |
( |
|
( |
|
|
|
( |
|
Net premiums earned |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss and loss adjustment expenses |
( |
|
( |
|
( |
|
( |
|
Net policy acquisition expenses |
( |
|
( |
|
( |
|
( |
|
Underwriting Income |
|
|
|
|
|
|
|
Supplementary Financial Information - Segment Results (Unaudited)
|
For the year ended |
|||||||
|
(in millions of |
Specialty |
|
Specialty |
|
Reinsurance |
|
Total |
|
Underwriting revenues |
|
|
|
|
|
|
|
|
Gross written premiums |
|
|
|
|
|
|
|
|
Ceded written premiums |
( |
|
( |
|
- |
|
( |
|
Net written premiums |
|
|
|
|
|
|
|
|
Net change in unearned premiums |
|
|
( |
|
( |
|
( |
|
Net premiums earned |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss and loss adjustment expenses |
( |
|
( |
|
( |
|
( |
|
Net policy acquisition expenses |
( |
|
( |
|
( |
|
( |
|
Underwriting income |
|
|
|
|
|
|
|
|
For the year ended |
|||||||
|
(in millions of |
Specialty |
|
Specialty |
|
Reinsurance |
|
Total |
|
Underwriting revenues |
|
|
|
|
|
|
|
|
Gross written premiums |
|
|
|
|
|
|
|
|
Ceded written premiums |
( |
|
( |
|
- |
|
( |
|
Net written premiums |
|
|
|
|
|
|
|
|
Net change in unearned premiums |
( |
|
( |
|
( |
|
( |
|
Net premiums earned |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss and loss adjustment expenses |
( |
|
( |
|
( |
|
( |
|
Net policy acquisition expenses |
( |
|
( |
|
( |
|
( |
|
Underwriting Income |
|
|
|
|
|
|
|
Notes to the Consolidated Financial Statements (Unaudited)
|
(1) |
The following are the calculated investment yields and the reconciliation of investment income included in the Consolidated Statements of Income (Unaudited) to net investment income: |
|
|
Quarter Ended |
|
Year Ended |
|||||
|
(in millions of |
2023 |
|
2022 |
|
2023 |
|
2022 |
|
|
Investment income (a) |
|
|
|
|
||||
|
Plus |
|
|
|
|
||||
|
Net realized gain (loss) on investments |
|
( |
|
( |
||||
|
Net unrealized gain (loss) on investments |
|
|
|
( |
||||
|
Change in allowance for expected credit losses on investments |
|
( |
|
( |
||||
|
Net investment income |
|
|
|
|
||||
| Average total investments and cash and cash equivalents (b) |
|
|
|
|
|
Investment Yield (a) / (b) annualized |
4.3% |
2.9% |
3.9% |
2.4% |
|
(2) |
Represents net income for the period available to common shareholders divided by the weighted average number of vested common shares – diluted calculated as follows: |
|
Quarter Ended |
|
Year Ended |
||||||
|
(in millions of |
2023 |
|
2022 |
|
2023 |
|
2022 |
|
|
Net income for the period |
|
|
|
|
||||
|
Minus: Net income attributable to the earnout shares |
|
|
|
|
||||
|
Minus: Dividends attributable to restricted share awards |
- |
- |
- |
|
||||
|
Net income available to common shareholders (a) |
|
|
|
|
||||
|
Weighted average number of shares – diluted (in millions of shares) (b)* |
43.1 |
45.6 |
43.5 |
45.7 |
||||
|
Diluted earnings per share attributable to equity holders (a/b) |
|
|
|
|
||||
|
* |
The weighted average number of common shares refers to the number of common shares calculated after adjusting for the changes in issued and outstanding common shares over a reporting period. |
Non-GAAP Financial Measures
In presenting IGI’s financial results, management has included and discussed certain non-GAAP financial measures. We believe that these non-GAAP measures, which may be defined and calculated differently by other companies, help to explain and enhance the understanding of our results of operations. However, these measures should not be viewed as a substitute for those determined in accordance with
Reconciliation of Combined Ratio to Accident Year Combined Ratio Prior to CAT Losses
The table below illustrates the reconciliation of the combined ratio on a financial and accident year basis.
|
|
Quarter Ended |
|
Year Ended |
|||||
|
(In millions of |
2023 |
|
2022 |
|
2023 |
|
2022 |
|
|
Net premiums earned (a) |
|
|
|
|
||||
|
Net loss and loss adjustment expenses (b) |
( |
( |
( |
( |
||||
|
Net policy acquisition expenses (c) |
( |
( |
( |
( |
||||
|
General and administrative expenses (d) |
( |
( |
( |
( |
||||
|
Prior years unfavorable (favorable) development (e) |
|
|
( |
( |
||||
|
Catastrophe (“CAT”) losses (f)* |
|
|
|
|
||||
|
|
|
|
|
|
||||
|
Combined ratio ((b+c+d)/a)** |
81.8% |
92.1% |
76.7% |
78.5% |
||||
|
Minus: Prior years unfavorable (favorable) development (e/a) |
2.9% |
4.3% |
(8.8%) |
(11.2%) |
||||
|
Accident year combined ratio |
78.9% |
87.8% |
85.5% |
89.7% |
||||
|
Minus: CAT losses on an accident year basis (f/a) |
8.3% |
12.5% |
8.6% |
6.5% |
||||
|
Accident year combined ratio prior to CAT losses |
70.6% |
75.3% |
76.9% |
83.2% |
||||
|
|
|
|
* |
The CAT losses for the fourth quarter ended |
|
|
|
|
|
The CAT losses for the year ended |
|
|
|
|
** |
See “Supplementary Financial Information - Combined Ratio (Unaudited)” |
Non-GAAP Financial Measures
The table below illustrates the split of loss ratio between current accident year, current year CAT losses, which are included in ‘Net loss and loss adjustment expenses’, and prior years’ loss development is as follows:
|
Quarter Ended |
|
Year Ended |
||||||||||||||
|
2023 |
|
2022 |
|
2023 |
|
2022 |
||||||||||
|
(in millions of |
Net loss |
|
% of net |
|
Net loss |
|
% of net |
|
Net loss |
|
% of net |
|
Net loss |
|
% of net |
|
|
Current year net incurred claims |
|
47.6% |
|
55.6% |
|
42.3% |
|
41.9% |
||||||||
|
Minus: Current accident year CAT losses |
|
8.3% |
|
12.5% |
|
8.6% |
|
6.5% |
||||||||
|
Minus: Effect of prior years’ development |
|
2.9% |
|
4.3% |
( |
(8.8%) |
( |
(11.2%) |
||||||||
|
Current Accident year (Prior to CAT losses) |
|
36.4% |
|
38.8% |
|
42.5% |
|
46.6% |
||||||||
Core Operating Income
Core operating income measures the performance of our operations without the influence of after-tax gains or losses on investments and foreign currencies and other items as noted in the table below. We exclude these items from our calculation of core operating income because the amounts of these gains and losses are heavily influenced by, and fluctuate in part according to, economic and other factors external to the Company and/or transactions or events that are typically not a recurring part of, and are largely independent of, our core underwriting activities and including them distorts the analysis of trends in our operations. We believe the reporting of core operating income enhances an understanding of our results by highlighting the underlying profitability of our core insurance operations. Our underwriting profitability is impacted by earned premiums, the adequacy of pricing, and the frequency and severity of losses. Over time, such profitability is also influenced by underwriting discipline, which seeks to manage the Company’s exposure to loss through favorable risk selection and diversification, IGI’s management of claims, use of reinsurance and the ability to manage the expense ratio, which the Company accomplishes through the management of acquisition costs and other underwriting expenses.
In addition to presenting net income for the period determined in accordance with
Non-GAAP Financial Measures
Core operating income is calculated by the addition or subtraction of certain line items reported in the “Consolidated Statements of Income” from net income for the period and tax effecting each line item (resulting in each item being a non-GAAP measure), as illustrated in the table below:
|
|
Quarter Ended |
|
Year Ended |
|||||
|
(in millions of |
2023 |
|
2022 |
|
2023 |
|
2022 |
|
|
|
|
|
||||||
|
Net income for the period |
|
|
|
|
||||
|
Reconciling items between net income for the period and core operating income: |
|
|
|
|
||||
|
Net realized (gain) loss on investments |
( |
|
( |
|
||||
|
Net unrealized (gain) loss on investments (tax adjusted) (i) |
( |
( |
( |
|
||||
|
Change in allowance for expected credit losses on investments (tax adjusted) (i) |
( |
|
( |
|
||||
|
Change in fair value of derivative financial liabilities |
|
|
|
( |
||||
|
Expenses related to conversion of warrants in cash (ii) |
( |
- |
|
- |
||||
|
Net foreign exchange (gain) loss (tax adjusted) (i) |
( |
( |
( |
|
||||
|
Core operating income |
|
|
|
|
||||
|
Average shareholders’ equity (iii) |
|
|
|
|
||||
|
Core operating return on average equity (annualized) (iv) and (vi) |
23.7% |
13.7% |
28.1% |
23.7% |
||||
|
Diluted core operating earnings per share (v) |
|
|
|
|
||||
|
Return on average equity (annualized) (vi) |
26.1% |
22.7% |
24.8% |
22.5% |
||||
|
i. |
Represents a non-GAAP financial measure as line-item balances have been adjusted for the related tax impact. |
|
|
ii. |
This expense is included in ‘Other expenses’ line item in the Consolidated Statements of Income. |
|
|
iii. |
Represents the total shareholders’ equity at the reporting period end plus the total shareholders’ equity as of the beginning of the reporting period, divided by 2. |
|
|
iv. |
Represents annualized core operating income for the period divided by average shareholders’ equity. |
|
|
v. |
Represents core operating income attributable to vested equity holders divided by weighted average number of vested common shares –diluted as follows: |
|
Quarter Ended
|
|
Year Ended
|
||||||
|
(in millions of |
2023 |
|
2022 |
|
2023 |
|
2022 |
|
|
Core operating income for the period |
|
|
|
|
||||
|
Minus: Core operating income attributable to earnout shares |
|
|
|
|
||||
|
Minus: Dividends attributable to restricted share awards |
- |
- |
- |
|
||||
|
Core operating income available to common shareholders (a) |
|
|
|
|
||||
|
Weighted average number of shares – diluted (in millions of shares) (b) |
43.1 |
45.6 |
43.5 |
45.7 |
||||
|
Diluted core operating earnings per share (a/b) |
|
|
|
|
||||
|
vi. |
Return on average equity (annualized) and core operating return on average equity (annualized), both non-GAAP financial measures, represent the returns generated on common shareholders’ equity during the period. |
The Company has posted a Fourth Quarter 2023 investor presentation deck on its website at www.iginsure.com in the Investors section under the Presentations & Webcasts tab.
About
Forward-Looking Statements:
This press release contains “forward-looking statements” within the meaning of the “safe harbour” provisions of the Private Securities Litigation Reform Act of 1995. The expectations, estimates, and projections of the business of
src="https://cts.businesswire.com/ct/CT?id=bwnewssty=20240312756164r1sid=acqr8distro=nxlang=en" style="width:0;height:0" />
View source version on businesswire.com: https://www.businesswire.com/news/home/20240312756164/en/
Investors:
M: + 44 (0) 7384 514785
Email: [email protected]
Media:
Aaida Abu Jaber, AVP PR Marketing
T: +96265662082 Ext. 407
M: +962770415540
Email: [email protected]
Source:



Clover Health Reports Fourth Quarter and Full Year 2023 Financial Results; Delivers Continued Momentum in Financial Performance and Provides Full-Year 2024 Guidance
IGI Declares Extraordinary Cash Dividend and Regular Ordinary Common Share Dividend
Advisor News
- Take advantage of the exploding $800B IRA rollover market
- Study finds more households move investable assets across firms
- Could workplace benefits help solve America’s long-term care gap?
- The best way to use a tax refund? Create a holistic plan
- CFP Board appoints K. Dane Snowden as CEO
More Advisor NewsAnnuity News
- $80k surrender charge at stake as Navy vet, Ameritas do battle in court
- Sammons Institutional Group® Launches Summit LadderedSM
- Protective Expands Life & Annuity Distribution with Alfa Insurance
- Annuities: A key tool in battling inflation
- Pinnacle Financial Services Launches New Agent Website, Elevating the Digital Experience for Independent Agents Nationwide
More Annuity NewsHealth/Employee Benefits News
- Universal health care: The moral cause
- IOWA REPUBLICANS GET WHAT THEY VOTED FOR: HIGHER HEALTH INSURANCE PRICES, FEWER PEOPLE ENROLLED IN THE ACA
- XAVIER RECEIVES $3 MILLION FOR OCHSNER MEDICAL SCHOOL SCHOLARSHIPS
- Gov. Phil Scott, officials detail health reform measures
- Idaho is among the most expensive states to give birth in. Here are the rankings
More Health/Employee Benefits NewsLife Insurance News
- AllianzIM Buffered ETF Suite Expands with Launch of International Fund
- Author Sherida Stevens's New Audiobook, “INDEXED UNIVERSAL LIFE INSURANCE IN ACTION: FROM PROTECTION TO PROSPERITY – YOUR PATH TO FINANCIAL SECURITY,” is Released
- AM Best Affirms Credit Ratings of Etiqa General Insurance Berhad
- Life insurance application activity hits record growth in 2025, MIB reports
- AM Best Revises Outlooks to Positive for Well Link Life Insurance Company Limited
More Life Insurance News